C. Antza, I. Doundoulakis, S. Stabouli, V. Kotsis
Renin-angiotensin-aldosterone system blockers are important drugs for the treatment of hypertension and its complications such as arterial stiffening, left ventricular hypertrophy and microalbuminuria. New drugs in this category are in request and research is ongoing to find new agents. Azilsartan was discovered in such an effort. This newly approved angiotensin-receptor blocker has similar properties with previous drugs of the same category, but seems to be more effective in the treatment of hypertension. In this review, the pharmacology, the adverse events and the differences to other drugs of the same category in the efficacy on reducing blood pressure will be discussed.
Keywords: azilsartan, arb, raas, hypertension